Targeted treatment plus chemotherapy could benefit women with ovarian cancer
Saturday, October 12, 2013 - 10:30
in Health & Medicine
Conventional chemotherapy could further extend life in some women with ovarian cancer when used in tandem with a new type of targeted treatment, a new international study shows. The research provides important evidence that PARP inhibitor drugs and chemotherapy can both be effective in the same patients, helping women live longer than they would if treated with chemotherapy alone.